Provided by Tiger Fintech (Singapore) Pte. Ltd.

Puma Biotechnology

3.13
+0.08932.94%
Volume:335.06K
Turnover:1.04M
Market Cap:155.25M
PE:5.05
High:3.17
Open:3.08
Low:3.04
Close:3.04
Loading ...

Er-Kim Announces Exclusive Distribution Agreement With Puma Biotechnology to Commercialize Nerlynx® (Neratinib) for Breast Cancer Patients

THOMSON REUTERS
·
Yesterday

Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients

GlobeNewswire
·
Yesterday

Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025

Business Wire
·
29 Apr

Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results

Business Wire
·
25 Apr

Is the Options Market Predicting a Spike in Puma Biotechnology Stock?

Zacks
·
21 Apr

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
03 Apr

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
03 Apr

Puma Biotechnology, Inc. (NASDAQ:PBYI) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Simply Wall St.
·
28 Mar

Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025

Business Wire
·
26 Mar

Puma Biotechnology (PBYI): One of the Best Short-Term Stocks to Buy Right Now

Insider Monkey
·
18 Mar

We Think Puma Biotechnology's (NASDAQ:PBYI) Healthy Earnings Might Be Conservative

Simply Wall St.
·
07 Mar

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
06 Mar

Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference

Business Wire
·
06 Mar

Are Investors Undervaluing Puma Biotechnology (PBYI) Right Now?

Zacks
·
03 Mar

Puma Biotechnology’s Earnings Call: Mixed Sentiments and Future Outlook

TIPRANKS
·
01 Mar

Q4 2024 Puma Biotechnology Inc Earnings Call

Thomson Reuters StreetEvents
·
01 Mar

Puma Biotechnology Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
28 Feb

Puma Biotechnology Inc (PBYI) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ...

GuruFocus.com
·
28 Feb

Puma Biotechnology Reports Strong Earnings Growth in 2024

TIPRANKS
·
28 Feb

Puma Biotechnology: Hold Rating Amidst Flat Sales Growth and Uncertain Drug Prospects

TIPRANKS
·
28 Feb